Neutra Corp. (NTRR)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Mar 9, 2026, 9:30 AM EST
Neutra Revenue
Neutra had revenue of $32.38K in the quarter ending April 30, 2024, with 454.18% growth. This brings the company's revenue in the last twelve months to $66.07K, up 2.95% year-over-year. In the fiscal year ending January 31, 2024, Neutra had annual revenue of $39.53K, down -41.86%.
Revenue (ttm)
66.07K
Revenue Growth
+2.95%
P/S Ratio
9.21
Revenue / Employee
4.40K
Employees
15
Market Cap
608.58K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2024 | 39.53K | -28.46K | -41.86% |
| Jan 31, 2023 | 68.00K | -24.02K | -26.10% |
| Jan 31, 2022 | 92.01K | 82.33K | 849.87% |
| Jan 31, 2021 | 9.69K | 3.29K | 51.48% |
| Jan 31, 2020 | 6.40K | - | - |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
| Jan 31, 2016 | Pro | Pro | Pro |
| Jan 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Demand Brands | 165.00K |
| CBD Life Sciences | 178.45K |
| Premier Biomedical | 14.28K |
| Cannabis Global | 1.06M |
| TransGlobal Assets | 91.35K |
| Grapefruit USA | 34.85K |
| Nutra Pharma | 392.15K |
| Global Roundtable | 1.24M |